Made by SterisWHO-GMP

St Gliptin M 50/1000

by Steris Healthcare Pvt. Ltd.

Be the first to review

Sitagliptin 50 mg + Metformin Hydrochloride 1000 mg

ST-GLIPTIN M50/1000 (Sitagliptin 50 mg & Metformin Hydrochloride Sustained Release 1000 mg Tablets), manufactured by Steris Healthcare, is an effective dual-action oral anti-diabetic medication. It is indicated for the management of type 2 diabetes mellitus in adult patients when single-drug therapy is insufficient to achieve optimal blood glucose control.

View medicine information ↓
Choose a pack
₹344.53₹492.1930% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹17.23 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

ST-GLIPTIN M50/1000 by Steris Healthcare brings together two complementary blood sugar-lowering agents: Sitagliptin (50 mg) and Metformin Hydrochloride Sustained Release (1000 mg). By pairing a selective DPP-4 inhibitor with a biguanide, this dual-combination therapy targets type 2 diabetes through two distinct mechanisms—boosting glucose-dependent insulin secretion and improving peripheral insulin sensitivity. Key Uses & Clinical Benefits: Dual-Mechanism Glycemic Control: Effectively lowers both fasting and postprandial (post-meal) blood glucose levels, helping patients reach and maintain target HbA1c goals. Incretin Enhancement: Sitagliptin (a DPP-4 inhibitor) prolongs the active life of incretin hormones (GLP-1 and GIP), boosting natural insulin release in response to meals while suppressing excessive glucagon secretion. Reduces Hepatic Glucose Production: Metformin SR decreases glucose production in the liver, reduces intestinal glucose absorption, and enhances peripheral tissue sensitivity to insulin. Sustained-Release Convenience: The 1000 mg Sustained Release (SR) Metformin matrix ensures controlled drug delivery throughout the day, minimizing common gastrointestinal side effects like nausea and stomach upset. Low Risk of Hypoglycemia & Weight-Neutral Profile: Operates via glucose-dependent pathways, delivering effective glycemic management with a low risk of sugar crashes and no added body weight gain. How ST-GLIPTIN M50/1000 Works: Sitagliptin (50 mg): Prevents the enzymatic degradation of incretin hormones by DPP-4, increasing mealtime insulin production and curbing post-meal glucagon release. Metformin SR (1000 mg): Activates AMP-activated protein kinase (AMPK) in liver tissue to suppress gluconeogenesis and optimize cellular response to circulating insulin.

How to use

Take 1 tablet of ST-GLIPTIN M50/1000 once or twice daily with meals (preferably with breakfast or evening meal) or as directed by your physician. Taking the medication with food helps reduce gastrointestinal discomfort associated with Metformin. Swallow the tablet whole with a glass of water—do not crush, chew, or break the tablet, as doing so disrupts the sustained-release delivery mechanism.

Storage

Store in a cool, dry place away from direct sunlight, light, and moisture. Store at a controlled room temperature below 30°C. Keep out of reach and sight of children.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid drinking alcohol while taking ST-GLIPTIN M50/1000, as excessive intake significantly increases the risk of Metformin-associated lactic acidosis and low blood sugar.

PregnancyConsult your doctor

ST-GLIPTIN M50/1000 is generally not recommended during pregnancy. Consult your physician for safer alternatives, such as insulin therapy.

BreastfeedingConsult your doctor

Do not use ST-GLIPTIN M50/1000 while breastfeeding without medical evaluation, as active ingredients may pass into human milk and affect the nursing infant.

DrivingConsult your doctor

ST-GLIPTIN M50/1000 alone usually does not cause hypoglycemia. However, exercise caution if taken in combination with sulfonylureas or insulin, as low blood sugar may affect your ability to drive.

KidneyConsult your doctor

Contraindicated in severe renal impairment (eGFR < 30 mL/min/1.73 m²). Renal function should be evaluated prior to initiating treatment and monitored regularly.

LiverConsult your doctor

Avoid use in patients with clinical or laboratory evidence of hepatic impairment due to the increased risk of lactic acidosis associated with Metformin.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Your feedback helps other customers make informed choices.

0/3000 charactersChecking your sign-in status…

Frequently viewed together

Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch
Rx · H
Linaliglip Empamet product pack

Linaliglip Empamet

For 15 Tablets

Empagliflozin 25 mg + Linagliptin 5 mg + Metformin 1000 mg

No reviews
₹154.00₹220.0030% off
Prescription required before dispatch
Rx · H
Acarbzone M 500 product pack

Acarbzone M 500

For 10 Tablet

Acarbose 50 mg + Metformin 500 mg

No reviews
₹108.22₹154.6030% off
Prescription required before dispatch
Rx · H
Acarbzone 25 product pack

Acarbzone 25

For 10 Tablet

Acarbose 25 mg

No reviews
₹52.83₹75.4730% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.